Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: Efficacy and safety studies of mometasone furoate nasal spray

World Allergy Organization Journal

Volumn 6, Issue 1, 2013, Pages

  Meltzer, Eli O ^a   Baena Cagnani, Carlos E ^b   Gates, Davis ^c   Teper, Ariel ^c  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergic rhinitis; Controlled clinical trial; Efficacy; Mometasone furoate nasal spray; Nasal congestion; Pediatric; Placebo; Safety

Indexed keywords

MOMETASONE FUROATE; NOSE SPRAY; PLACEBO;

ARTICLE; ASTHMA; BACTERIAL INFECTION; BRONCHITIS; CHILD; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; DERMATITIS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; DYSPNEA; ECZEMA; EPISTAXIS; ERYTHEMA; FATIGUE; FEMALE; FEVER; HAY FEVER; HUMAN; HYPOKINESIA; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NASAL BURNING; NAUSEA; NOSE IRRITATION; NOSE OBSTRUCTION; OTITIS MEDIA; PATHOLOGICAL CRYING; PERENNIAL RHINITIS; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SNEEZING; THORAX PAIN; TREATMENT DURATION; URTICARIA; VIRUS INFECTION; VOMITING;

EID: 84887836331     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1186/1939-4551-6-5     Document Type: Article

References (26)

1. Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, et al: Burden of allergic rhinitis: results from the pediatric allergies in America survey. J Allergy Clin Immunol 2009, 124:S43-S70.
2. Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D, ISAAC Phase III Study Group: Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the international study of asthma and allergies in childhood.. Pediatr Allergy Immunol 2008, 19:110-124. (Pubitemid 351197288)
3. Mansfield LE, Diaz G, Posey CR, Flores-Neder J: Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide.. Ann Allergy Asthma Immunol 2004, 92:240-244. (Pubitemid 38233663)
4. Gupta N, Smith AW, Kapur P, Kearney S, Silverman B, Emre U, Schneider AT: Allergic rhinitis and inner-city children-is there a relationship to sleepdisordered breathing? Pediatr Asthma Allergy Immunol 2009, 22:7-14.
5. De Freitas F C N, Bastos EP, Primo LS, De Freitas VL: Evaluation of the palate dimensions of patients with perennial allergic rhinitis. Int J Paediatr Dent 2001, 11:365-371. (Pubitemid 33673173)
6. Meltzer EO, Berger WE, Berkowitz RB, Bronsky EA, Dvorin DJ, Finn AF, Galant SP, Grossman J, Hampel FC, Ratner PH, et al: A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis.. J Allergy Clin Immunol 1999, 104:107-114. (Pubitemid 29364488)
7. Baena-Cagnani CE, Patel P: Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergic rhinitis.. Curr Med Res Opin 2010, 26:2047-2055. 2011
8. Meltzer EO, Shekar T, Teper AA: Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.. Allergy Asthma Proc 2011, 32:159-167.
9. Wandalsen GF, Mendes AI, Solé D: Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis.. Am J Rhinol Allergy 2010, 24:e32-e36.
10. Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS, Rooklin A, Rosen JP, Ruff ME, Vandewalker ML, Wanderer A, et al: Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.. Pediatrics 2000, 105:E22
11. Brannan MD, Herron JM, Affrime MB: Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther 1997, 19:1330-1339. (Pubitemid 28133271)
12. Sibbald B, Rink E: Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991, 46:895-901.
13. Scadding GK, Richards DH, Price MJ: Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis.. Clin Otolaryngol Allied Sci 2000, 25:551-557. (Pubitemid 32002870)
14. Ciprandi G, Cirillo I, Vizzaccaro A, Tosca M, Passalacqua G, Pallestrini E, Canonica GW: Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy 2005, 60:882-887 (Pubitemid 40813809)
15. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334.
16. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, Van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ, Global Allergy and Asthma European Network: Grading of recommendations assessment, development and evaluation working group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010, 126:466-476.
17. Da Silva CH, Silva TE, Morales NM, Fernandes KP, Pinto RM: Quality of life in children and adolescents with allergic rhinitis. Braz J Otorhinolaryngol 2009, 75:642-649.
18. Shedden A Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med 2005, 4:439-446.
19. Li AM, Au CT, So HK, Lau J, Ng PC, Wing YK: Prevalence and risk factors of habitual snoring in primary school children. Chest 2010, 138:519-527.
20. Abreu RR, Rocha RL, Lamounier JA, Guerra AF: Etiology, clinical manifestations and concurrent findings in mouth-breathing children. J Pediatr (Rio J) 2008, 84:529-535
21. Juliano ML, Machado MA, De Carvalho LB, Zancanella E, Santos GM, Do Prado LB, Do Prado GF: Polysomnographic findings are associated with cephalometric measurements in mouth-breathing children.. J Clin Sleep Med 2009, 5:554-561
22. Juliano ML, Machado MA, Carvalho LB, Prado LB, Do Prado GF: Mouth breathing children have cephalometric patterns similar to those of adult patients with obstructive sleep apnea syndrome.. Arq Neuropsiquiatr 2009, 67:860-865.
23. Fernández RP, Díez Jde M, Alvarez-Perea A, Tapia PM, García RJ, Gómez-Piñán VS: Risk factors for asthma onset between the ages of 12 and 40. Results of the FENASMA study. Arch Bronconeumol 2011, 47:433-440
24. Modrzynski M, Zawisza E: An analysis of the incidence of adenoid hypertrophy in allergic children. Int J Pediatr Otorhinolaryngol 2007, 71:713-719. (Pubitemid 46628712)
25. Tomonaga K, Kurono Y, Mogi G: The role of nasal allergy in otitis media with effusion. A clinical study. Acta Otolaryngol Suppl 1988, 458:41-47
26. Brawley A, Silverman B, Kearney S, Guanzon D, Owens M, Bennett H, Schneider A: Allergic rhinitis in children with attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol 2004, 92:663-667. (Pubitemid 39243158)